ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Shalby Earnings Call: Key Takeaways

Shalby Limited reports Q4 FY26 consolidated revenue growth of 9.4% YoY. The company is scaling its MedTech implant business and expanding hospital capacity through an asset-light O&M model.

Highlights
Revenue growth9.4% YoY for Q4 FY26; 4.8% for full year FY26.
MarginsConsolidated EBITDA margin stable at 14.5% for FY26.
Demand visibilityStrong; ~3.5 million patients served since inception.
Management confidenceHigh focus on Arthroplasty leadership and technology-led homecare expansion.

Growth

FY26 Consolidated Revenue up 4.8% to ₹11,682 mn; FY26 PAT grew 1706% to ₹347 mn due to tax adoption.

Outlook

Targeting 200-bed Asha Parekh Hospital by 2030-31; focusing on doubling ROCE via operational leverage and asset-light expansion.

Risks

International segment (Shalby International) reported EBITDA losses of ₹42 mn for FY26; hospital occupancy remains low at 48%.

Source

Earnings Call filed with NSE, NSE: SHALBY. Summary written with AI assistance from the document.

Read the document ↗

Shalby Ltd: key numbers

Share price
₹126.99
Market cap
₹1,372 Cr
Revenue (annual)
₹1,141 Cr
Net profit (annual)
₹37.39 Cr
P/E (TTM)
35.0×Sector 54.5×
Promoter holding
74.33%+0.00% QoQ
FII holding
4.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shalby Ltd

All →